Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T8962 | TM5007 | 342595-05-5 | 98% |
![]() |
TM5007 is a poent inhibitor of plasminogen activator inhibitor-1 (PAI-1; IC50 of 29 uM). | ||||
T29856 | Aleplasinin | 481629-87-2 | 98% |
![]() |
Aleplasinin is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Alepl... | ||||
T23764 | AZ3976 | 1418747-15-5 | 98% |
![]() |
AZ3976 is an inhibitor of PAI-1 with an IC50 of 16 μM in a plasma clot lysis assay. AZ3976 displays profibrinolytic activities. | ||||
T13257 | Upamostat | 590368-25-5 | 98% |
![]() |
Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor. | ||||
T4254 | TM5441 | 1190221-43-2 | 98% |
![]() |
TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor 1 (PAI-1). | ||||
T9947 | GW-6604 | 452342-37-9 | 98% |
![]() |
GW-6604 is an ALK5 inhibitor and shows clear antifibrotic effects resulting in liver function improvement. | ||||
T3442 | UK-371804 | 256477-09-5 | 98% |
![]() |
UK-371804 is an effective and specific uPA inhibitor. It was selected as a candidate for further preClinicalal evaluation for the treatment of chronic dermal ulc... | ||||
T2030 | Tiplaxtinin | 393105-53-8 | 98% |
![]() |
Tiplaxtinin(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM. | ||||
T4255 | TM5275 sodium | 1103926-82-4 | 98% |
![]() |
TM5275 is an inhibitor of plasminogen activator inhibitor 1 (PAI-1). | ||||
T4S0592 | Toddalolactone | 483-90-9 | 98% |
![]() |
anti-inflammatory and analgesic. | ||||
T3876 | Loureirin B | 119425-90-0 | 98% |
![]() |
Loureirin B can downregulate the expression of fibrosis-related molecules by regulating MMPs and TIMPs levels, inhibit scar fibroblast proliferation and suppress... |